Canada: Life Sciences, Biotechnology & Nanotechnology

Subscribe

Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.

Federal Court Provides Process Guidance For Summary Judgment Motions And Trials

On June 22, 2026, the Federal Court released an amended version of the Case and Trial Management Guidelines for Complex Proceedings, Proceedings under the PM(NOC) Regulations, and Appeals under Subsection 56(1) of the Trademarks Act (the “Guidelines”).

SB

Smart & Biggar

Health Canada Finalizes Biosimilar Guidance: Comparative Clinical Efficacy Studies Not Typically Required

In Canada, biosimilar products are approved by way of a new drug submission, following Health Canada guidance first released in 2010 and significantly revised in 2016. Such guidance had, in most cases, required comparative clinical efficacy and safety trials between the biosimilar and reference product. In 2025, Health Canada consulted on a revised draft guidance document for biosimilar submissions, which notably proposed removing the requirement for comparative clinical efficacy and safety trials.

Canada Healthcare

SB

Smart & Biggar

Santé Canada Met Au Point Ses Lignes Directrices Sur Les Biosimilaires : Les Études Cliniques Comparatives Sur L’efficacité Ne Sont Généralement Pas Nécessaires

Au Canada, les biosimilaires sont approuvés par voie de présentations de drogues nouvelles selon les lignes directrices initialement publiées par Santé Canada en 2010...

Canada Healthcare

SB

Smart & Biggar

Transfer Pricing Rules In Canada

On March 26, 2026, Canada's new transfer pricing rules received royal assent and will have a significant impact on multi-national enterprises (MNEs) in life sciences industries.

BJ

Bennett Jones LLP

The Life Sciences Boom: H2 2026 Outlook

Worldwide Healthcare

BJ

Bennett Jones LLP

Medical Devices Updates: Mandatory Use Of The Regulatory Enrolment Process For Medical Devices And Updated Guidance Documents Related To The Regulatory Enrolment Process

Canada Healthcare

SB

Smart & Biggar

Health Canada Publishes Medical Devices Directorate Quarterly Performance Reports For Q2 And Q3 Of 2025/2026

Canada Healthcare

SB

Smart & Biggar

Life Sciences Outlook 2026

Canada Healthcare

BJ

Bennett Jones LLP

BCF Acts As Counsel To Celystra Pharma As Part Of An Equity Investment

Canada Healthcare

BB

BCF Business Law

Santé Canada sollicite des commentaires sur la mise en œuvre progressive de la liste incorporée par renvoi dans le cadre de l’arrêté ministériel relatif à la confiance

Canada Healthcare

SB

Smart & Biggar

Ontario Superior Court Limits Damages Claims In Certifying Personal Injury Medical Device Class Action

Canada Litigation

BJ

Bennett Jones LLP

Northern Advantage: Canada's Federal Court As A Venue For Pharmaceutical Patent Litigation

BJ

Bennett Jones LLP

Mise à jour sur les instruments médicaux : utilisation obligatoire du processus d’inscription réglementaire pour les instruments médicaux et mise à jour des lignes directrices relatives à ce processus

Canada Healthcare

SB

Smart & Biggar

Deference Prevails: A Public Drug Funding Decision In Québec Is Upheld On Reasonableness Review

Canada Healthcare

TL

Torys LLP

What Do I Need To Know About Contingent Value Rights?

Canada Commercial

BC

Blake, Cassels & Graydon LLP

Crypto Tax Lawyer's Guide To DeFi, Yield Farming, & Liquidity In 2026

RS

Rotfleisch & Samulovitch P.C.

International Crypto Fraud Crackdown: How CRA Treats Tax Losses From Crypto Scams In Canada

RS

Rotfleisch & Samulovitch P.C.

Walking The Journey With Founders: Joe Gill’s Approach To Supporting Saskatchewan Startups (Video)

Canada Commercial

ML

McKercher LLP

Duty To Inquire About Disabilities: Key Lessons From A Recent Ontario Human Rights Decision

Canada Employment

F

Fasken

Class Action Pursued Over Infection Risks Linked To Endoscope Devices

A proposed Canadian class action has been commenced alleging that certain endoscope devices may expose patients to serious and potentially life-threatening infections.

Canada Consumer

SL

Siskinds LLP

Tout ce qu'il faut savoir sur les lignes directrices mises à jour et les exemples 2026 de l'OPIC concernant l'objet brevetable

Le 25 mars 2026, l'Office de la propriété intellectuelle du Canada (l'« OPIC ») a publié de nouvelles lignes directrices concernant l'interprétation...

SB

Smart & Biggar

Canada Announces New Pharmaceutical And Life Sciences Sector Task Force

On March 18, 2026, the federal Minister of Health announced the creation of the Pharmaceutical and Life Sciences Sector Task Force, a joint initiative led by Health Canada and Innovation...

Canada Healthcare

SB

Smart & Biggar

PMPRB Consults On Proposed Practice Directions For PMPRB Hearings

The  Patented Medicine Prices Review Board (PMPRB) holds public hearings on two types of matters...

SB

Smart & Biggar

Le CEPMB lance une consultation concernant le projet de directives relatives à la pratique pour ses audiences

Canada Technology

SB

Smart & Biggar

Changing Life Sciences' Patent Landscape: It's Time To Talk About Efficient Licensing

GW

Gowling WLG

L'intelligence artificielle prescrira-t-elle bientôt des médicaments au Canada? Les leçons du programme novateur de l'Utah

Canada Healthcare

FF

Fasken (French)

Updated Guidance From CIPO On Patentable Subject-Matter

ML

McMillan LLP

Could Artificial Intelligence Soon Prescribe Drugs In Canada? Lessons From Utah's Landmark Program

Canada Healthcare

F

Fasken

Torys On Defence: The Role Of Life Sciences In Canada's Defence Capabilities

Canada Healthcare

TL

Torys LLP

PMPRB Launches Consultation On Proposed Practice Directions For Hearings

Canada Healthcare

MT

McCarthy Tétrault LLP

Federal Court Denies Class Action Certification In Generic Drug Price Fixing Case

Canada Healthcare

SB

Smart & Biggar

La Cour fédérale rejette une requête en autorisation de recours collectif relative à la fixation des prix de médicaments génériques

Canada Healthcare

SB

Smart & Biggar

Update On Proposed Ministerial Reliance Order

Canada Healthcare

SB

Smart & Biggar

PMPRB Launches Consultation On Proposed Practice Directions For Hearings

The Patented Medicine Price Review Board (PMPRB) has opened a public consultation on proposed Practice Directions governing PMPRB hearings.

Canada Healthcare

MT

McCarthy Tétrault LLP

Federal Court Denies Class Action Certification In Generic Drug Price Fixing Case

The Federal Court has dismissed a request to certify a proposed class proceeding against a large number of generic...

Canada Healthcare

SB

Smart & Biggar

La Cour fédérale rejette une requête en autorisation de recours collectif relative à la fixation des prix de médicaments génériques

La Cour fédérale a rejeté une requête pour obtenir l'autorisation d'exercer un recours collectif contre un grand nombre de fabricants de médicaments génériques nommés comme défenderesses ...

Canada Healthcare

SB

Smart & Biggar

Update On Proposed Ministerial Reliance Order

As we reported last month, the Minister of Health launched a consultation on a proposed Ministerial Reliance Order that would permit Health Canada to complete the examination of certain parts...

Canada Healthcare

SB

Smart & Biggar

Mise à jour sur la proposition d'arrêté ministériel relatif à la confiance

Canada Healthcare

SB

Smart & Biggar

U.S. Supreme Court Strikes Down Key Trump Tariffs, But New Measures May Follow

In a significant decision with immediate global trade ramifications, the U.S. Supreme Court has invalidated a series...

Canada International

GW

Gowling WLG

Healthcare Supply Chains: Managing Modern Slavery Risks In Hospital Procurement

Healthcare organizations should be aware of growing scrutiny over supply chain practices, including with respect to risks of forced and child labour and modern slavery.

Canada Healthcare

BL

Borden Ladner Gervais LLP

Une proposition d'arrêté ministériel relatif à la confiance pourrait permettre à Santé Canada d'avoir recours à des décisions prises par des autorités réglementaires étrangères reconnues

Le 19 décembre 2025, la ministre de la Santé a annoncé le lancement de consultations sur deux initiatives réglementaires...

Canada Healthcare

SB

Smart & Biggar

Les 10 articles incontournables de la Mise à jour en PI Rx en 2025

Voici les articles les plus lus de la rubrique Mise à jour en PI Rx en 2025...

Canada Healthcare

SB

Smart & Biggar

Top Ten Rx IP Update Reads Of 2025

SB

Smart & Biggar

Top Ten Rx IP Update Reads Of 2025

SB

Smart & Biggar

Canada Accelerates Regulatory Modernization

Canada Healthcare

BJ

Bennett Jones LLP

Les faits saillants de 2025 au Canada en matière de PI en sciences de la vie et de droit réglementaire

Canada Healthcare

SB

Smart & Biggar

2025 Highlights In Canadian Life Sciences IP And Regulatory Law

Canada Healthcare

SB

Smart & Biggar

Santé Canada lance une consultation sur deux documents d'ébauche de lignes directrices sur les conditions pour les médicaments à usage humain et vétérinaire ainsi que les présentations de drogues basées sur des preuves prometteuses d'efficacité clinique

Canada Healthcare

SB

Smart & Biggar

Proposal For Modernizing Clinical Trial Framework Aims To Improve Access To New And Innovative Therapies In Canada

Canada Healthcare

SB

Smart & Biggar

Une proposition de modernisation du cadre des essais cliniques pour favoriser l'accès à de nouvelles thérapies innovantes au Canada

Canada Healthcare

SB

Smart & Biggar

Cancer-linked Drug And Product Lawsuits: Legal Pathways For Affected Patients

Canada Healthcare

SL

Siskinds LLP

Naming Natural Health Products: Branding In A Grey Zone

Canada Healthcare

ML

McMillan LLP

Proposed New Requirements For Lithium-Ion Batteries In Consumer Products

Canada Consumer

GR

Gardiner Roberts LLP

How Is AI Transforming The Life Sciences Industry?

Canada Technology

TL

Torys LLP

What You Should Know About The Freestyle Libre 3 Recall

Worldwide Litigation

GP

Gluckstein Lawyers

VC Investment In Canada For Life Sciences Companies

Canada Healthcare

MT

McCarthy Tétrault LLP

Mise à jour sur le CEPMB : Entrée en vigueur des Lignes directrices pour le personnel du CEPMB le 1er janvier 2026 et Rapport annuel 2024

Canada Healthcare

SB

Smart & Biggar

See more

Latest Videos

See more

Lifecycle Of A Smart Idea | Patent Strategy: Optimizing Life Sciences Patents

GW

Gowling WLG

Lois canadiennes, américaines, britanniques et européennes entourant l'Internet des objets (Video)

BL

Borden Ladner Gervais LLP

The Legal Steps To Startups: Health & Life Science (Video)

PM

Parlee McLaws

Navigating Life Sciences Procurement And Responding To RFPs (Video)

TL

Torys LLP

Canada's Healthcare Industry After COVID-19: Legal, Medical And Business Perspectives (Video)

SE

Stikeman Elliott LLP

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More